| Primary |
| Arthritis |
18.2% |
| Arthralgia |
13.6% |
| Neck Pain |
13.6% |
| Product Used For Unknown Indication |
13.6% |
| Muscle Pain |
9.1% |
| Musculoskeletal Pain |
9.1% |
| Pain |
9.1% |
| Degenerative Disc Disease |
4.5% |
| Pain In Extremity |
4.5% |
| Pain Relief |
4.5% |
|
| Thermal Burn |
30.8% |
| Blister |
7.7% |
| Pain |
7.7% |
| Application Site Pain |
3.8% |
| Application Site Vesicles |
3.8% |
| Burns Second Degree |
3.8% |
| Drug Eruption |
3.8% |
| Erythema |
3.8% |
| Incorrect Route Of Drug Administration |
3.8% |
| Insomnia |
3.8% |
| Pain Of Skin |
3.8% |
| Product Container Issue |
3.8% |
| Rash |
3.8% |
| Skin Burning Sensation |
3.8% |
| Skin Erosion |
3.8% |
| Somnolence |
3.8% |
| Urticaria |
3.8% |
|
| Secondary |
| Neuropathy Peripheral |
29.3% |
| Pain |
24.4% |
| Product Used For Unknown Indication |
6.1% |
| Depression |
4.9% |
| Herpes Zoster |
4.9% |
| Back Injury |
3.7% |
| Blood Triglycerides Increased |
3.7% |
| Convulsion |
3.7% |
| Spinal Disorder |
3.7% |
| Urticaria |
3.7% |
| Blood Cholesterol |
2.4% |
| Blood Pressure |
2.4% |
| Neuralgia |
2.4% |
| Blood Cholesterol Abnormal |
1.2% |
| Blood Cholesterol Increased |
1.2% |
| Hypertension |
1.2% |
| Infection |
1.2% |
|
| Drug Ineffective |
21.1% |
| Somnolence |
15.8% |
| Abdominal Pain Upper |
10.5% |
| Oedema Peripheral |
10.5% |
| Rash Erythematous |
10.5% |
| Application Site Burn |
5.3% |
| Blood Pressure Fluctuation |
5.3% |
| Drug Ineffective For Unapproved Indication |
5.3% |
| Insomnia |
5.3% |
| Self Injurious Behaviour |
5.3% |
| Tachypnoea |
5.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.0% |
| Pain |
9.1% |
| Chronic Obstructive Pulmonary Disease |
8.2% |
| Hypertension |
7.2% |
| Diabetes Mellitus |
7.0% |
| Multiple Myeloma |
4.1% |
| Constipation |
3.4% |
| Drug Use For Unknown Indication |
3.2% |
| Thrombosis Prophylaxis |
3.2% |
| Back Pain |
2.9% |
| Depression |
2.9% |
| Osteoarthritis |
2.9% |
| Pain In Extremity |
2.7% |
| Breast Cancer |
2.5% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Parkinson's Disease |
2.5% |
| Analgesic Therapy |
2.3% |
| Arthralgia |
2.1% |
| Hypercholesterolaemia |
2.1% |
| Muscle Spasms |
2.1% |
|
| Delirium |
8.3% |
| Myocardial Infarction |
6.9% |
| Pharmaceutical Product Complaint |
6.9% |
| Decreased Appetite |
5.6% |
| Deep Vein Thrombosis |
5.6% |
| Mental Status Changes |
5.6% |
| Oedema Peripheral |
5.6% |
| Urosepsis |
5.6% |
| Vomiting |
5.6% |
| Infection |
4.2% |
| Laceration |
4.2% |
| Pleural Effusion |
4.2% |
| Product Quality Issue |
4.2% |
| Rash |
4.2% |
| Respiratory Arrest |
4.2% |
| Staphylococcal Skin Infection |
4.2% |
| Tongue Haemorrhage |
4.2% |
| Vision Blurred |
4.2% |
| Weight Increased |
4.2% |
| Agitation |
2.8% |
|
